Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002654669 | SCV003521625 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550446 | SCV004113053 | uncertain significance | JAG1-related disorder | 2024-02-17 | no assertion criteria provided | clinical testing | The JAG1 c.3410A>G variant is predicted to result in the amino acid substitution p.Lys1137Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0099% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |